Related Experiment Videos
Decreased MK-801 binding in discrete hippocampal regions of prion-infected mice
M Diez1, S J DeArmond, D Groth
1Department of Neuroscience, Karolinska Institutet, S-171 77 Stockholm, Sweden. Margarita.Diez@neuro.ki.se
Abstract:
The neurochemical alterations associated with neurodegeneration in prion diseases are not well defined. It is therefore of interest to study the influence of prion infection on messenger molecules and their receptors. In the present study we have analyzed the possible involvement of NMDA receptors in prion-infected mice using ligand binding autoradiography and iodinated MK-801, a noncompetitive NMDA antagonist. The results show a reduced binding of MK-801 in discrete regions of hippocampus at 110 days after infection, that is before the appearance of behavioral symptoms. In addition, early transient increases in MK-801 binding were observed in several layers. The exact neuroanatomical correlate of these changes in MK-801 binding, as well as its functional significance in relation to prion symptomatology, remain to be analyzed.
Insights
Prion infection alters NMDA receptor binding in mouse brains before symptoms appear. Researchers observed reduced MK-801 binding in the hippocampus, indicating early neurochemical changes in prion disease.
Area of Science:
- Neuroscience
- Prion Diseases
- Neurodegeneration
Background:
- Neurochemical alterations in prion diseases are not well understood.
- Investigating the impact of prion infection on neurotransmitter systems is crucial.
Purpose of the Study:
- To investigate the role of NMDA receptors in prion-infected mice.
- To analyze changes in NMDA receptor binding during prion disease progression.
Main Methods:
- Ligand binding autoradiography was employed.
- Iodinated MK-801, a noncompetitive NMDA antagonist, was used.
Main Results:
- Reduced MK-801 binding was observed in specific hippocampal regions 110 days post-infection, preceding behavioral symptoms.
- Early, transient increases in MK-801 binding were detected in several brain layers.
Conclusions:
- NMDA receptor binding undergoes significant changes in the early stages of prion disease.
- These alterations in MK-801 binding may represent an early biomarker for prion neurodegeneration.